ABSTRACT
S
tructural abnormalities underlying temporal and frontal lobe epilepsies have been well described. 1, 2 Little is known about the type and frequency of structural brain abnormalities that give rise to insular/peri-insular cortex epilepsy (IPICE). 3 The insula is a highly developed structure, totally encased within the brain in the depths of the Sylvian fissure and covered by the frontal, parietal, and temporal opercula. 4 Insular seizures are typically associated with a sensation of laryngeal constriction and paresthesias affecting perioral or large cutaneous territories with preserved consciousness, followed by dysarthric speech and/or elementary auditory hallucinations or motor signs. 5 Later observations have also showed that insular seizures could feature hypermotor symptoms resembling frontal lobe seizures, 6 early visceral signs or dysphasia with subsequently altered consciousness suggesting temporal lobe seizures, and early somatosensory symptoms in the absence of laryngeal constriction mimicking parietal lobe seizures. 7 The purpose of our study was to ascertain 1) the overall type and distribution of structural abnormalities, identified by MR imaging, in association with IPICE; and 2) their refractoriness to antiepileptic drug therapy.
CASE SERIES

Materials and Methods
Charts from all patients seen at the epilepsy clinic by one of the authors (D.K.N.) from August 2002-May 2010 were reviewed retrospectively to find patients with IPICE. Patients were classified as having 1) definite IPICE when insular seizures were confirmed by intracerebral recordings; 2) probable IPICE in partial epilepsy with early ictal somatosensory symptoms and/or a sensation of laryngeal constriction associated with insular/peri-insular lesions; and 3) possible IPICE in partial epilepsy with early viscerosensory symptoms, speech arrest, dysphasia, or hypermotor ictal manifestations coupled with insular/peri-insular lesions on MR imaging or clear insular activation on ictal SPECT. Pharmacoresistance was defined as failure of the epilepsy to be controlled with 3 appropriate antiepileptic drug trials.
Imaging protocols varied because this study was retrospective, and some imaging was performed at referring centers. Most were standard MR imaging protocols, tumor protocols, or epilepsy protocols. MR imaging scans of all patients with IPICE were reviewed retrospectively by a neuroradiologist with 15 years of experience and a senior resident in radiology. The following features were noted: type of structural abnormality, anatomic location, and extent.
For statistical analysis, patients were partitioned within 6 radiopathologic categories: 1 (neoplastic), 2 (malformations of cortical development [MCDs], 3 (vascular malformations), 4 (atrophy/gliosis from acquired insults), 5 (other), and 6 (normal). A 2 ϫ 6 contingency table was constructed partitioning patients between pharmacoresistant and responsive to medication. A Fisher exact test was performed on this 2 ϫ 6 contingency table assuming that categories are mutually exclusive, followed by a Fisher exact test for each category when appropriate. A Bonferroni correction was used to control for multiplicity (␣ ϭ 0.05/6 or ␣ ϭ 0.008). For each category presenting a significant association with pharmacoresistance, the risk was reported with a 95% CI. Calculations were produced on StatsDirect statistical software (version 2.7.9, http://www.statsdirect.com).
RESULTS
A total of 59 (6.4%) of 920 patients with epilepsy had IPICE. Eleven patients were excluded because MR imaging scans of 5 patients were destroyed, no MR imaging scans were taken of 2 patients because of contraindications (eg, pacemaker), and MR imaging was not available before surgical treatment in 4 patients. Hence, we retrospectively reviewed the MR imaging results of 48 patients with IPICE. Of these patients, 7 had definite IPICE, 24 had probable IPICE, and 17 had possible IPICE. The group included 21 men and 27 women with a median age of 39 years (age range, 2-73 years).
The On-line Table lists the pathologic patterns detected on MR imaging in the 48 patients and refractoriness to antiepileptic drug treatment. It disclosed neoplastic lesions in 13 patients (27%). Eight patients presented pathologic features compatible with low-grade glioma and 5 patients, with high-grade glioma. Eight patients had astrocytomas (Fig 1) , 4 of which were lowgrade, and 4 were high-grade. Three patients had low-grade oligoastrocytoma. MR imaging results in these patients demonstrated infiltrative masses centered over the insula with extension to the frontal and temporal lobes. One patient, who had a previously resected, low-grade oligodendroglioma, went on to have IPICE many years later in the context of insular tumor recurrence. Another patient had glioblastoma multiforme involving the insula and the temporal operculum.
MCDs were detected in 10 patients (20%). Five patients had cortical dysplasia involving the insula; 4 had polymicrogyria implicating the insula with perisylvian extension (Fig 2) , including 1 patient with bilateral perisylvian polymicrogyria; and another patient had tuberous sclerosis presenting multiple cortical tubers, 1 being located in the operculoinsular region (Fig 3) . Vascular malformations were found in 9 patients (19%). Four patients had an arteriovenous malformation (Fig 4) with a nidus in the insula or inducing a FLAIR signal abnormality in the insula. Three patients had a Sylvian bifurcation aneurysm with mass effect on the insular cortex, and 2 others had a cavernoma centered on the insula (Fig 5) .
Atrophy/gliosis from acquired insults was observed in 8 patients (17%). Two patients had encephalomalacia and atrophy after trauma (Fig 6) : one involving the temporal operculum and insula after surgical evacuation of a hematoma, and the other involving the insula and frontal and temporal opercula. One patient had signs of an old ischemic infarct exclusively in the insular cortex. Another patient had cystic encephalomalacia after herpes encephalitis affecting the insula and temporal lobes. Yet another patient had encephalomalacia and atrophy after a congenital insult, 2 patients had encephalomalacia and atrophy of indeterminate cause involving the insula and the frontal or temporal opercula, and 1 other patient had pial enhancement over the insula and frontal operculum of unknown cause. Serial MR imaging in a patient with Rasmussen encephalitis revealed an initial insular FLAIR signal abnormality followed by unilateral fronto-temporoinsular atrophy and gliosis. A millimetric, innocuous-looking T2 signal abnormality over the posterior insula was found in 1 patient. A neuroepithelial cyst vs a signal abnormality in the insula was seen in another patient. One patient had no insular lesions (despite depth electrode-proven insular seizures) but rather hippocampal sclerosis (and concomitant hippocampal seizures). MR imaging results were normal in 4 patients: 2 of whom had definite IPICE, and 2 of whom had possible IPICE.
Among the 43 patients with lesions in the insula, damage was confined to the insular cortex with or without involvement of the adjacent operculum in 20 patients. More than 1 operculum was affected in the remaining 23 patients.
Refractoriness to antiepileptic drug treatment was 100% for the 10 patients with MCD (1.0; 95% CI, 0.72-1.0), 50.0% (0.5; 95% CI, 0.21-0.78) in the presence of atrophy/gliosis from acquired insults, 39% (0.39; 95% CI, 0.14 -0.68) for neoplastic lesions, and 22.2% (0.22; 95% CI, 0.06 -0.55) for vascular mal-
formations. An estimated 75% of patients with normal MR imaging results (0.75; 95% CI, 0.19 -0.99) had refractory epilepsy (Table 1 ). The patient with Rasmussen encephalitis had refractory epilepsia partialis continua with occasionally complex partial seizures.
DISCUSSION
Some epileptogenic lesions are more commonly found in certain regions of the brain. For example, typical epileptogenic lesions diagnosed in patients with temporal lobe epilepsy are hippocampal atrophy/sclerosis, dysembryoplastic neuroepithelial tumors, gangliogliomas, postherpetic encephalitic gliosis, and posttraumatic encephalomalacia. 2, 8, 9 Until now, little was known about the epileptogenic lesions associated with IPICE. In our study, 13 patients (27%) with IPICE manifested tumors, 8 of whom had low-grade gliomas. Duffau et al 10 had previously reported that the insular cortex itself may induce chronic seizures when injured by tumors. In 2010, Lee et al 11 observed that 34% of patients with high-grade tumors and 62% of those with low-grade tumors had epilepsy. Among patients with lowgrade gliomas, those with tumors located in the temporal lobe as well as in the insular region were more likely to present with seizures. MCDs constitute 4%-25% of all epileptogenic lesions in adults and 10%-50% in pediatric populations. [12] [13] [14] Our study determined that 10 patients (20.8%) with IPICE had MCDs, 4 (8.3%) of whom had perisylvian polymicrogyria. This preferential localization in the perisylvian area for polymicrogyria has been well demonstrated by Leventer et al, 15 who found this pattern in 200 (61%) of 328 patients. Cortical tubers, which histologically resemble cortical dysplasias, can also induce seizures in this zone. 16 Nine patients (18.8%) with IPICE had vascular lesions. By its very location, the insula is susceptible to vascular lesions. 17 It is closely related to the Sylvian artery, from which it receives its blood supply via numerous perforating arteries from the M2 and M3 segments. As reported by Malak et al, 18 unruptured Sylvian bifurcation aneurysms can present with a combination of viscerosensitive, motor, language, autonomic, and somatosensory symptoms related to the proximity of the insula. Arteriovenous malformations and cavernomas can also cause IPICE by direct compression or hemorrhage. Any previous intracranial insult can result in epilepsy. In our series, 8 patients (17%) with IPICE had atrophy or encephalomalacia from acquired insults. Trauma and herpes encephalitis classically injure the temporal lobes, but damage may extend to the insula. Although strokes are the most common source of epilepsy in elderly people, they were not found here to be a cause of IPICE, likely because of the rare occurrence of pure insular ischemic strokes. 19 One patient with IPICE had Rasmussen encephalitis, a chronic inflammatory disease of unknown origin affecting 1 hemisphere. 20 Some imaging studies have previously suggested that the progressive hemiatrophy associated with Rasmussen encephalitis starts preferentially in the insula and in the perisylvian area. [21] [22] [23] Refractoriness to antiepileptic drug treatment was 100% for MCDs in the insular/peri-insular region, which is not necessarily surprising, as such entities located in other areas are generally linked with drug-resistant epilepsies as well. 3 The refractoriness rate was 38.5% (5/13) for patients with tumors in our series, most of which were low-grade gliomas (4/5; 80%). These findings are consistent with the observations of Duffau et al, 10 who recorded a refractoriness rate of 58% with insular low-grade gliomas and suggested that the latter are more prone to eliciting drug-resistant epilepsy than tumors invading other brain structures. 10, 24 Although half (2/4) of patients with IPICE related to atrophy/gliosis had drug-resistant seizures, their low number did not allow further interpretation. Although some studies have reported a high rate of drug-resistant seizures in posttraumatic 25, 26 or postencephalitic epilepsies, 27 epilepsies after strokes usually respond to medical treatment. 28 Of interest, 1 patient with a millimetric T2 signal abnormality in the posterior insula (initially dismissed as nonspecific), 1 patient with hippocampal sclerosis but no insular lesion, and 3 of 4 patients with normal MR imaging results had refractory insular seizures confirmed by invasive recordings. This finding raises the possibility that a certain proportion of patients with persisting seizures, despite temporal, frontal, or parietal lobe epilepsy surgeries, might have unrecognized IPICE. 29, 30 The limitations of our study are inherent to any retrospective design. Because MR imaging scans were not standardized (magnet strength, acquisition protocols), anatomic delineation of insular involvement was constrained in some cases. Coronal and sagittal T2-weighted sequences with thin sections on the insula would certainly have increased the precision. Although the lesions were centered on the insular/peri-insular area, some extended slightly beyond, and we cannot exclude that seizures originated from adjacent lobes with rapid propagation to the insular/peri-insular area. Finally, selecting patients from a specialized epilepsy clinic in a tertiary academic center may have biased the study into finding a higher rate of lesions associated with intractable epilepsy. 
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